Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ
Journal of Drugs in Dermatology · 01.05.2026 · 25 (5) · 454-459
DOI: 10.36849/jdd.9192 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.04.2026. Verfasst von Mark S Nestor und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Aminolevulinic Acid, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, Facial Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Nestor, M. S., Chaudry, A., Vanaria, R. J., & Bhupalam, V. (2026). Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ. Journal of Drugs in Dermatology, 25(5), 454-459. https://doi.org/10.36849/jdd.9192
Vancouver
Nestor MS, Chaudry A, Vanaria RJ, Bhupalam V. Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ. Journal of Drugs in Dermatology. 2026;25(5):454-459. doi:10.36849/jdd.9192
BibTeX
@article{Nestor2026,
author = {Nestor, Mark S and Chaudry, Aysham and Vanaria, Robert J and Bhupalam, Vishnu},
title = {Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {5},
pages = {454--459},
doi = {10.36849/jdd.9192}
}
EUVIMED